Abstract
Familial Mediterranean Fever (FMF) is the most frequent autoinflammatory disease. This study aimed to evaluate the risk of subclinical vascular damage in FMF children, and young adults, using both imaging and laboratory tests. Forty-five FMF patients (mean age 14.3 ± 9.5 years, 33 children) and 44 healthy controls(mean age 13.3 ± 8.6 years, 36 children) were included in the study. The patients were diagnosed according to Tel-Hashomer criteria, were positive for MEFV gene mutation, were treated with colchicine and were evaluated during an attack free-period. The arterial stiffness parameters studied were carotid–femoral pulse wave velocity (PWV), Augmentation Index (Aix), subendocardial viability ratio (SEVR) and carotid intima-media thickness (cIMT). Laboratory parameters, inflammation markers and lipid profile were also evaluated for all participants. There were no significant differences between patients and healthy individuals, as well as in our children population regarding PWV, SEVR, Aix and cIMT. However, significantly higher ESR, CRP and fibrinogen levels were detected in the total population of FMF patients and higher amyloid levels in FMF children, compared to controls. Atherogenic Index of Plasma was significantly higher both in the total patient population and in the subgroup of children, compared to controls. Furthermore, a significant positive correlation between Aix and CRP and a negative correlation between SEVR and ESR became apparent in the pediatric subgroup. Our study demonstrated no significant differences in vascular measurements between FMF patients and controls. The above could be attributed to the regular colchicine treatment, which seems to have a cardioprotective role against vascular damage.
Similar content being viewed by others
Abbreviations
- AIP:
-
Atherogenic index of plasma
- Aix:
-
Augmentation index
- ApoA1:
-
Apolipoprotein A1
- ApoB:
-
Apolipoprotein B
- BMI:
-
Body mass index
- BP:
-
Blood pressure
- cDBP:
-
Central diastolic blood pressure
- cfPWV:
-
Carotid to femoral pulse wave velocity
- cIMT:
-
Carotid intima-media thickness
- cSBP:
-
Central systolic blood pressure
- CRP:
-
C-reactive protein
- CVD:
-
Cardiovascular disease
- dBP:
-
Brachial diastolic blood pressure
- ESR:
-
Erythrocyte sedimentation rate
- ESC:
-
European society of cardiology
- FMF:
-
Familial mediterranean fever
- HDL-C:
-
High-density lipoprotein-cholesterol
- ISSF:
-
International Severity Scoring System for Familial Mediterranean Fever
- LDL-C:
-
Low-density lipoprotein-cholesterol
- Lp(a):
-
Lipoprotein (a)
- MEFV:
-
Familial mediterranean fever gene
- PWV:
-
Pulse wave velocity
- sBP:
-
Brachial systolic blood pressure
- SEVR:
-
Subendocardial viability ratio
- TC:
-
Total cholesterol
- TG:
-
Triglycerides
References
Shahbaznejad L, Raeeskarami SR, Assari R, Shakoori A, Azhideh H, Aghighi Y, Tahghighi F, Ziaee V (2018) Familial Mediterranean gene (MEFV) mutation in parents of children with familial Mediterranean fever: what are the exceptions? Int J Inflam 2018:1902791. https://doi.org/10.1155/2018/1902791
Alghamdi M (2017) Familial Mediterranean fever, review of the literature. Clin Rheumatol 36(8):1707–1713. https://doi.org/10.1007/s10067-017-3715-5
Kelesoglu FM, Aygun E, Okumus NK, Ersoy A, Karapinar E, Saglam N, Aydin NG, Senay BB, Gonultas S, Sarisik E, Can MZ, Atay S, Basbug D, Tiryaki FK, Ozer S, Durmus RB, Orem F, Atay T, Acar A, Yilmaz Y, Kaya S, Ciftkaya A, Sarac Z, Makar CC, Saracoglu B, Dogdu G, Omeroglu RE (2016) Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol 35(11):2757–2763. https://doi.org/10.1007/s10067-016-3275-0
Alsarah A, Alsara O, Laird-Fick HS (2017) Cardiac manifestations of familial Mediterranean fever. Avicenna J Med 7(4):158–163. https://doi.org/10.4103/ajm.AJM_78_17
Rodriguez AJ (2017) Vascular risk in familial Mediterranean fever. Anatol J Cardiol 17(2):139. https://doi.org/10.14744/AnatolJCardiol.2016.22571
Mozos I, Malainer C, Horbanczuk J, Gug C, Stoian D, Luca CT, Atanasov AG (2017) Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol 8:1058. https://doi.org/10.3389/fimmu.2017.01058
Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine-update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 45(3):341–350. https://doi.org/10.1016/j.semarthrit.2015.06.013
Savant JD, Furth SL, Meyers KE (2014) Arterial stiffness in children: pediatric measurement and considerations. Pulse (Basel) 2(1–4):69–80. https://doi.org/10.1159/000374095
Mikael LR, Paiva AMG, Gomes MM, Sousa ALL, Jardim P, Vitorino PVO, Euzebio MB, Sousa WM, Barroso WKS (2017) Vascular aging and arterial stiffness. Arq Bras Cardiol 109(3):253–258. https://doi.org/10.5935/abc.20170091
Vampertzi O, Papadopoulou-Legbelou K, Triantafyllou A, Douma S, Papadopoulou-Alataki E (2020) Familial Mediterranean fever and atherosclerosis in childhood and adolescence. Rheumatol Int 40(1):1–8. https://doi.org/10.1007/s00296-019-04457-8
Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P (2019) Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol 30(6):918–928. https://doi.org/10.1681/ASN.2019020117
Namba T, Masaki N, Takase B, Adachi T (2019) Arterial stiffness assessed by cardio-ankle vascular index. Int J Mol Sci 20(15):3664. https://doi.org/10.3390/ijms20153664
Anyfanti P, Gkaliagkousi E, Triantafyllou A, Dipla K, Zarifis H, Arseniou P, Lazaridis A, Douma S (2019) Noninvasive assessment of myocardial perfusion in different blood pressure phenotypes and its association with arterial stiffness indices. Am J Hypertens 32(6):557–563. https://doi.org/10.1093/ajh/hpz039
Anyfanti P, Triantafyllou A, Gkaliagkousi E, Triantafyllou G, Koletsos N, Chatzimichailidou S, Panagopoulos P, Botis I, Aslanidis S, Douma S (2017) Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors. Clin Rheumatol 36(6):1229–1236. https://doi.org/10.1007/s10067-017-3659-9
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885. https://doi.org/10.1002/art.1780401023
Yilmaz F, Ulu S, Akci O, Ahsen A, Demir K, Yuksel S (2014) Evaluation of arterial stiffness with plasma GGT levels and pulse wave velocity measurement in patients with FMF. Eur J Rheumatol 1(1):11–13. https://doi.org/10.5152/eurjrheum.2014.003
Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, Turker T, Karadag O, Livneh A, Ben-Chetrit E, Ozen S, Vasculitis FMFA, Orphan disease Research in pediatric, r. (2016) Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis 75(6):1051–1056. https://doi.org/10.1136/annrheumdis-2015-208671
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I, List of authors, Task Force, m. (2018) 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC task force for the management of arterial hypertension. J Hypertens 36(12):2284–2309. https://doi.org/10.1097/HJH.0000000000001961
Expert Panel on Integrated Guidelines for Cardiovascular, Risk Reduction in Children (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl 5):S213-256. https://doi.org/10.1542/peds.2009-2107C
Herbert A, Cruickshank JK, Laurent S, Boutouyrie P, R Values for Arterial Measurements C. (2014) Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J 35(44):3122–3133. https://doi.org/10.1093/eurheartj/ehu293
Bo MS, Cheah WL, Lwin S, Moe Nwe T, Win TT, Aung M (2018) Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an university in Malaysia. J Nutr Metab 2018:7027624. https://doi.org/10.1155/2018/7027624
Mattace-Raso F, Hofman A, Verwoert GC, Wittemana JC, Wilkinson I, Cockcroft J, McEniery C, Yasmin Laurent S, Boutouyrie P, Bozec E, Hansen TW, Torp-Pedersen C, Ibsen H, Jeppesen J, Vermeersch SJ, Rietzschel E, De Buyzere M, Gillebert TC, Van Bortel L, Segers P, Vlachopoulos C, Aznaouridis C, Stefanadis C, Benetos A, Labat C, Lacolley P, Stehouwer C, Nijpels G, Dekker JM, Stehouwer C, Ferreira I, Twisk JW, Czernichow S, Galan P, Hercberg S, Pannier B, Guérin A, London G, Cruickshank JK, Anderson SG, Paini A, Agabiti Rosei E, Muiesan ML, Salvetti M, Filipovsky J, Seidlerova J, Dolejsova M (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J 31(19):2338–2350. https://doi.org/10.1093/eurheartj/ehq165
Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabo AJ, Benetos A, Salvi P (2010) Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 56(2):217–224. https://doi.org/10.1161/HYPERTENSIONAHA.110.152686
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, European Network for Non-invasive Investigation of Large A. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27(21):2588–2605. https://doi.org/10.1093/eurheartj/ehl254
van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM, Stehouwer CD (2014) Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 63(17):1739–1747. https://doi.org/10.1016/j.jacc.2013.12.041
Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soyturk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750. https://doi.org/10.1093/rheumatology/kei279
Bilginer Y, Ozaltin F, Basaran C, Duzova A, Besbas N, Topaloglu R, Ozen S, Bakkaloglu A (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28(12):1211–1216. https://doi.org/10.1007/s00296-008-0605-9
Acay A, Ulu MS, Ahsen A, Ozkececi G, Demir K, Ozuguz U, Yuksel S, Acarturk G (2014) Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever. Medicina (Kaunas) 50(6):329–333. https://doi.org/10.1016/j.medici.2014.11.009
Keles N, Aksu F, Aciksari G, Yilmaz Y, Demircioglu K, Kostek O, Cekin ME, Kalcik M, Caliskan M (2016) Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? North Clin Istanb 3(1):39–45. https://doi.org/10.14744/nci.2016.52824
Icli A, Cure E, Uslu AU, Sakiz D, Cure MC, Ozucan M, Baykara RA, Karakoyun A, Balta S, Ozturk C, Arslan S, Kucuk A (2017) The relationship between atherogenic index and carotid artery atherosclerosis in familial Mediterranean fever. Angiology 68(4):315–321. https://doi.org/10.1177/0003319716659220
Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sahin B, Seymen HO (2006) The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 22(13):1127–1131. https://doi.org/10.1016/s0828-282x(06)70949-7
Kozan M, Ozan ZT, Demir V, Ede H (2019) The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever. JRSM Cardiovasc Dis 8:2048004018823856. https://doi.org/10.1177/2048004018823856
Kaplanoglu H, Ozisler C (2018) Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with familial Mediterranean fever. J Ultrasound Med 37(7):1649–1656. https://doi.org/10.1002/jum.14512
Kukuy O, Livneh A, Mendel L, Benor A, Giat E, Perski O, Feld O, Kassel Y, Ben-Zvi I, Lidar M, Holtzman EJ, Leiba A (2017) Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine. Clin Exp Rheumatol 35(6):32–37
Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L, Karadag O, Ertenli I, Kiraz S, Aytemir K, Akata D, Tokgozoglu L, Oto A (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48(11):2351–2353. https://doi.org/10.1016/j.jacc.2006.09.013
Peru H, Altun B, Dogan M, Kara F, Elmaci AM, Oran B (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27(6):689–694. https://doi.org/10.1007/s10067-007-0764-1
Kucuk A, Uslu AU, Arslan S, Balta S, Ozturk C, Uysal S, Yilmaz R, Sakiz D, Kayrak M (2016) Ischemia-modified albumin and atherosclerosis in patients with familial Mediterranean fever. Angiology 67(5):456–460. https://doi.org/10.1177/0003319715595744
Mahmoud SSE, Ismail NA, Farag YM, Hashem RH, Ibrahim MH, Salah MM, Tous AN (2018) Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever. Arch Med Sci Atheroscler Dis 3:e106–e111. https://doi.org/10.5114/amsad.2018.77545
Ozalper V, Kara M, Tanoglu A, Cetindagli I, Ozturker C, Hancerli Y, Hira S, Kara K, Beyazit Y, Yazgan Y (2017) Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Rheumatol 36(9):2071–2077. https://doi.org/10.1007/s10067-016-3532-2
Kim M, Kim M, Yoo HJ, Lee SY, Lee SH, Lee JH (2018) Age-specific determinants of pulse wave velocity among metabolic syndrome components, inflammatory markers, and oxidative stress. J Atheroscler Thromb 25(2):178–185. https://doi.org/10.5551/jat.39388
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and literature searching were performed by OV, KP and SA. Vascular measurements were performed by AT. Data analysis was performed by AT and NK. The first draft of the manuscript was written by OV. KP and SD commented on previous versions of the manuscript. Data management, interpretation and supervising were done by EP. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Ethical approval
The study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The study protocol was approved by the Institutional Ethics Committee. Written informed consent of the subjects themselves or their guardians when age was lower than 18 years was obtained before inclusion in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vampertzi, O., Papadopoulou-Legbelou, K., Triantafyllou, A. et al. Assessment of vascular damage in children and young adults with Familial Mediterranean Fever. Rheumatol Int 42, 59–69 (2022). https://doi.org/10.1007/s00296-021-04991-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04991-4